Q2 2026 Alligator Bioscience AB Earnings Call Transcript
Welcome to Alligator Biosciences interim report call for the Second Quarter of 2026. My name is Greta Hoog. I am the IR and Communications Manager at Alligator and I will be introducing today's call. With me today is our CEO, Soren Bregenholt, and our CFO, Johan Gileus. They will walk you through the latest developments at the company, after which they will be happy to answer any questions you may have.
You may either submit these questions in the Q&A function of this chat or you may e-mail them to IR at alligatorbioscience.com.
As you know, Alligator Bioscience as a publicly listed company. And I would like to note that today's presentation may include forward-looking statements. Please refer to the disclaimer on this side and to the next slide for the whole presentation.
And with this, I would like to turn the call over to you, Soren.
Thank you, Greta. And once again, welcome
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
